Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Роль самостоятельного мониторирования гликемии в комплексном управлении сахарным диабетом типа 2
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Сунцов Ю.И. Современные сахароснижающие препараты, используемые в России при лечении сахарного диабета типа 2. Сахарный диабет. 2012; 1: 6–10.
2. DCCT Research Group: The relationship of a glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968–83.
3. Klein R. Hyperglycemia and microvascular disease in diabetes. Diabetes Care 1995; 18: 258–68.
4. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
5. Bonora E, Calcaterra F, Lombardi S et al. Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Diabetes Care 2001; 24: 2023–9.
6. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA1c affected by glycemic instability? Diabetes Care 2003; 26: 2728–33.
7. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26: 881–5.
8. Funatsu H, Yamashita H, Ohashi Y. Effect of rapid glicaemic control on progression of diabetic retinopathy. Jpn J Ophthalmol 1992; 36 (3): 356–67.
9. Boland E, Monsod T, Delucia M et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858–62.
10. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
11. Nolan J, Batin PhD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation 1998; 98: 1510–6.
12. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
13. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
14. Kleiger R, Bosner M. Correlation of time and freguence domain measures of heart rate variability. In: Noninvasive Electrocardiology. Clinical aspects of Holter monitoring. Ed.: A.Moss, S.Stern. Saunders Co, University Press. Cambridge UK 1997; p. 199–206.
15. Stefanidis A, Asimacopoulos P et al. Intensive insulin treatment reduces transient ischaemic episodes during acute events in diabetic patients. ESC Congress. J Eur Heart 2002; 23: 609.
16. Raine CH et al. Significant Insulin Dose Errors May Occur if Blood Glucose Results are Obtained from Miscoded Meters. Jour Diab Sci Tech 2007; 1(2): 205–10.
2. DCCT Research Group: The relationship of a glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968–83.
3. Klein R. Hyperglycemia and microvascular disease in diabetes. Diabetes Care 1995; 18: 258–68.
4. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
5. Bonora E, Calcaterra F, Lombardi S et al. Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Diabetes Care 2001; 24: 2023–9.
6. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA1c affected by glycemic instability? Diabetes Care 2003; 26: 2728–33.
7. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26: 881–5.
8. Funatsu H, Yamashita H, Ohashi Y. Effect of rapid glicaemic control on progression of diabetic retinopathy. Jpn J Ophthalmol 1992; 36 (3): 356–67.
9. Boland E, Monsod T, Delucia M et al. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858–62.
10. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59.
11. Nolan J, Batin PhD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation 1998; 98: 1510–6.
12. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
13. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
14. Kleiger R, Bosner M. Correlation of time and freguence domain measures of heart rate variability. In: Noninvasive Electrocardiology. Clinical aspects of Holter monitoring. Ed.: A.Moss, S.Stern. Saunders Co, University Press. Cambridge UK 1997; p. 199–206.
15. Stefanidis A, Asimacopoulos P et al. Intensive insulin treatment reduces transient ischaemic episodes during acute events in diabetic patients. ESC Congress. J Eur Heart 2002; 23: 609.
16. Raine CH et al. Significant Insulin Dose Errors May Occur if Blood Glucose Results are Obtained from Miscoded Meters. Jour Diab Sci Tech 2007; 1(2): 205–10.
Авторы
Н.А.Черникова
ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва
ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.